EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $199,393 | -70.7% | 168,977 | +205.1% | 0.00% | -80.0% |
| Q4 2020 | $681,000 | +508.0% | 55,389 | +302.8% | 0.01% | +150.0% |
| Q3 2020 | $112,000 | -60.6% | 13,751 | -67.0% | 0.00% | -71.4% |
| Q1 2020 | $284,000 | -84.8% | 41,714 | -66.7% | 0.01% | -36.4% |
| Q4 2019 | $1,866,000 | +55.2% | 125,220 | +6.8% | 0.01% | 0.0% |
| Q3 2019 | $1,202,000 | -7.5% | 117,250 | -4.3% | 0.01% | -15.4% |
| Q2 2019 | $1,299,000 | +89.1% | 122,569 | +149.4% | 0.01% | +85.7% |
| Q1 2019 | $687,000 | +84.7% | 49,141 | +34.1% | 0.01% | +75.0% |
| Q4 2018 | $372,000 | +204.9% | 36,647 | +259.3% | 0.00% | +300.0% |
| Q3 2018 | $122,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |